Table 1 from Repurposing Vandetanib plus Everolimus for the Treatment of &lt;i&gt;ACVR1&lt;/i&gt;-Mutant Diffuse Intrinsic Pontine Glioma

Diana Carvalho; Peter J. Richardson; Nagore G. Olaciregui; Reda Stankunaite; Cinzia Lavarino; Valeria Molinari; Elizabeth A. Corley; Daniel P. Smith; Ruth Ruddle; Adam Donovan; Ákos Pál; Florence I. Raynaud; Sara Temelso; Alan Mackay; John P. Overington; Anne M. Phelan; David N. Sheppard; Andrew L. MacKinnon; Bassel Zebian; Safa Al‐Sarraj; Ashirwad Merve; Jeremy Pryce; Jacques Grill; Michael Hubank; Ofelia Cruz; Andrés Morales La Madrid; Sabine Mueller; Ángel M. Carcaboso; Fernando Carceller; Chris Jones

doi:10.1158/2159-8290.30834229

Abstract

Demographics of three children with newly diagnosed ACVR1-mutant DIPG treated with vandetanib and mTOR inhibitors upfront or at relapse

Related Publications

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

Normand Laperrière , Lisa Zuraw , Gregory Cairncross

A systematic review was conducted to develop guidelines for radiotherapy in adult patients with newly diagnosed malignant glioma. MEDLINE, CANCERLIT, the Cochrane Library, and r...

2002 Radiotherapy and Oncology 421 citations

Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas

Chiaki Komine , Takao Watanabe , Yoichi Katayama +3 more

The O 6 ‐methylguanine‐DNA methyltransferase (MGMT) plays a major role in repairing DNA damage from alkylating agents. In several human neoplasms including low‐grade diffuse ast...

2003 Brain Pathology 137 citations

Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

René-Olivier Mirimanoff , Thierry Gorlia , Warren Mason +11 more

Purpose The European Organisation for Research and Treatment of Cancer and National Cancer Institute of Canada trial on temozolomide (TMZ) and radiotherapy (RT) in glioblastoma ...

2006 Journal of Clinical Oncology 501 citations

Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

Monika E. Hegi , Annie-Claire Diserens , Sophie Godard +7 more

Abstract Purpose: In the setting of a prospective clinical trial, we determined the predictive value of the methylation status of the O-6-methylguanine-DNA methyltransferase (MG...

2004 Clinical Cancer Research 779 citations

Clinical prognostic factors affecting survival in patients with newly diagnosed Glioblastoma Multiforme (GBM)

Thierry Gorlia , Roger Stupp , E. A. Eisenhauer +5 more

9599 Background:In the EORTC 26981–22981/NCIC CE3 phase III trial, 573 pts with newly diagnosed GBM were randomized to receive radiotherapy (RT) or RT plus Temozolomide (results...

2004 Journal of Clinical Oncology 6 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Table 1 from Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Diana Carvalho, 
                                
                                    Peter J. Richardson, 
                                
                                    Nagore G. Olaciregui
                                
                                et al.
                            
                            (2025). 
                            Table 1 from Repurposing Vandetanib plus Everolimus for the Treatment of &lt;i&gt;ACVR1&lt;/i&gt;-Mutant Diffuse Intrinsic Pontine Glioma. 
                            
                            .
                            https://doi.org/10.1158/2159-8290.30834229

Identifiers

DOI: 10.1158/2159-8290.30834229

Table 1 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma